| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | BCL-2 Inhibitor [EPC] | 14 | 0.0002 |
| 2 | Alkylating Drug [EPC] | 53 | 0.0002 |
| 3 | Topoisomerase Inhibitor [EPC] | 16 | 0.0002 |
| 4 | CD19-directed Chimeric Antigen Receptor [EPC] | 2 | 0.0002 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 53 | 0.0002 |
| 6 | Platinum-based Drug [EPC] | 14 | 0.0001 |
| 7 | Corticosteroid [EPC] | 54 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Thalidomide Analog [EPC] | 10 | 0.0000 |
| 10 | Leukocyte Growth Factor [EPC] | 2 | 0.0000 |
| 11 | Proteasome Inhibitor [EPC] | 1 | 0.0000 |
| 12 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 13 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 14 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |